BOSON Rapid Combo Test Kit COVID-19 IgG/IgM

General information: Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the name given to the 2019 novel coronavirus. COVID-19 is the name given to the disease associated with the virus. SARS-CoV-2 is a new strain of coronavirus that has not been previously identified in humans. The 2019-Novel Coronavirus belongs to the genus β. It has a capsule, and its particles are round or oval, often polymorphous, with a diameter of 60-140nm. Its genetic characteristics are significantly different from SARS-CoV and MERS-CoV. Rapid 2019-nCoV IgG/IgM Combo Test Card is an immunochromatography based one step in vitro test. It is designed for the rapid qualitative determination of IgG and IgM antibodies to 2019 novel coronavirus (2019-nCoV, SARS-CoV-2) in human serum, plasma, or whole blood. Rapid 2019-nCoV IgG/IgM Combo Test Card is a fabulous supplement detection for COVID-19 suspected infected patients besides nucleic acid test, which could greatly raise the accuracy of the detection for COVID-19. Reagents and materials supplied: Rapid 2019-nCoV IgG/IgM Combo Test Card Sample buffer 2 μL capillary pipet Instructions for Use Principle of the test: Results interpretation: Performance characteristics: Accuracy A total of 74 specimens from confirmed patients were tested, the results showed that 65 specimens were IgM positive or / and IgG positive, and the clinical sensitivity was 87.8%. A total of 305 specimens from healthy persons were tested, the results showed that 302 specimens were both IgM and IgG negative, 1 specimen was IgM positive, 2 specimens were IgG positive, and the clinical specificity was 99.0%. The accuracy was 96.8%. CE-IVD certificated